Nov 13, 2023 No Voluntary Delistings or Disputes in FDA's Orange Book Update By Chad Landmon Matt Murphy Ross Blau FTC recently placed improper Orange Book patent listings squarely in its crosshairs. In its September 2023 policy statement, FTC...
/Passle/64d4f6fee800c20fd466fd0c/SearchServiceImages/2023-11-10-15-51-34-976-654e5186a75a7bae70d926fd.jpg)
